3Endorf FW, Supple KG, Gamelli RL. The evolving characteristics and care of necrotizing soft-tissue infections [J]. Bums,2005,31(3):269-273.
4Belba MK, Belba GP. Review of statistical data about severe bum patients treated during 2001 and evidence of septic cases in Albania[J]. Bums,2004,30(8):813-819.
8Tsai WP, Chen CL, Ko WC, et al. Stenotrophomonas mahophilia bacteremia in bum patients[J]. Bums,2006,32 (2):155-158.
9Atiyeh BS, Costagliola M, Hayek SN, et al. Effect of silver on burn wound infection control and healing: review of the literature[J]. Bums,2007,33(2): 139-148.
10Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock[J]. Intensive Care Med,2004,30(4):536- 555.
5Goossens H,Ferech M,Vander Stichele R et al.Outpatient antibiotic use in Europe and association with resistance:a cross-national database study.Lancet,2005,365(9459):579.
6Marra F,Patrick DM,White R et al.Effect of formulary policy decisions on antimicrobial drug utilization in British Columbia.J Antimi crob Chemother,2005,55(1):95.
7Meyer E,Jonas D,Schwab F et al.Design of a surveillance system of antibiotic use and bacterial resistance in german intensive care units(SARI).Infection,2003,31(4):208.
8Rosenthal VD,Guzman S,Migone O et al.The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina:a prospective,matched analysis.Am J Infect Control,2005,33(3):157.
9Landman D,Chockalingam M,Quale JM.Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formu lary.Clin Infect Dis,1999,28(5):1062.
10Cizman M,Pokorn M,Seme K et al.The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens.J Antimicrob Chemother,2001,47(4):475.
